Share this post on:

Product Name :
Selatogrel

Search keywords :
Selatogrel

drugId :
null

Target Vo:
Purinergic receptor P2Y12

Target Vo Short Name :
P2RY12

Moa_Name:
Purinergic receptor P2Y12 antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Idorsia Pharmaceuticals Ltd

Active Company_Name :
Aiduoxi (Beijing) Pharmaceutical Co Ltd

Active Indication_Name:
Myocardial Infarction

In Active Indication_Name:
Coronary Artery Disease

Termination Status :

China Termination Status :

Highest Status:
Phase 3 Clinical

China Highest Status:
Phase 3 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
DDX3 Antibody (YA784)
Biotin-conjugated Anti-Mouse IgG H&L
Chk1 Antibody (YA505): Chk1 Antibody (YA505) is a non-conjugated and Rabbit origined monoclonal antibody about 54 kDa, targeting to Chk1. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse.

Share this post on:

Author: Interleukin Related